Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2023 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CYTOKINETICS INC | 3 | Q2 2024 | 9.7% |
ARGENX SE | 3 | Q2 2024 | 5.6% |
VERTEX PHARMACEUTICALS INC | 3 | Q2 2024 | 4.8% |
AXSOME THERAPEUTICS INC | 3 | Q2 2024 | 4.4% |
SAREPTA THERAPEUTICS INC | 3 | Q2 2024 | 4.7% |
KRYSTAL BIOTECH INC | 3 | Q2 2024 | 4.3% |
MIRUM PHARMACEUTICALS INC | 3 | Q2 2024 | 3.9% |
XENON PHARMACEUTICALS INC | 3 | Q2 2024 | 4.5% |
DEXCOM INC | 3 | Q2 2024 | 4.0% |
TRANSMEDICS GROUP INC | 3 | Q2 2024 | 3.7% |
View First Turn Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-13 |
13F-HR | 2024-08-08 |
13F-HR | 2024-05-06 |
13F-HR | 2024-02-08 |
View First Turn Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.